Dynamic Proteomics and Integrated Rates of Muscle Protein Synthesis During an Acute Period of Loading and Unloading

Exercise Clinical Trial

— HYPAT  

Official title:

Dynamic Proteomics and Integrated Rates of Muscle Protein Synthesis During an Acute Period of Hypertrophy and Atrophy (HYPAT) in Young, Healthy Men

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04514744
• Other study ID #: 10624
• Status: Active, not recruiting
• Phase: N/A
• Start date: December 30, 2021
• Est. completion date: July 1, 2024

Study information

• Verified date: October 2023
• Source: McMaster University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Skeletal muscle plays several different roles in the promotion and maintenance of health and well-being. The loss of muscle mass that occurs with aging, chronic muscle wasting diseases, and physical inactivity puts people at an increased risk of frailty and becoming insulin resistant, and therefore imposes a significant burden on health care spending. Resistance exercise participation has proven particularly effective for increasing muscle mass and strength. This effectiveness can be used by health care practitioners in a rehabilitation setting to promote the recovery of individuals who have undergone involuntary periods of muscular unloading (i.e. limb immobilization caused by a sports injury or reconstructive surgery). However, there is large variability in the amount of muscle mass and strength that people gain following participation in resistance exercise. Some individuals fail to increase the size of their muscle (low responders) whereas others show vary large increases in muscle size (high responders) in response to the same resistance training program. People also show differences in the amount of muscle tissue they lose when they have a limb immobilized. To circumvent variability across individuals, the investigators utilized a within-person paired Hypertrophy and Atrophy ('HYPAT') strategy that reduced response heterogeneity by ~40% (Available at: https://ssrn.com/abstract=3445673). Specifically, one leg performed resistance training for 10 weeks to induce hypertrophy, whereas the other leg underwent single-leg immobilization for 2 weeks to induce atrophy. The primary goal of the study will be to gain insight into the molecular responses to an acute period of single-leg immobilization and resistance exercise (8 days). The investigators will use an integrated systems biology approach to monitor the individual rates of over one hundred different muscle proteins.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 16
• Est. completion date: July 1, 2024
• Est. primary completion date: September 1, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 30 Years

Eligibility

Inclusion Criteria:

• Healthy males, between the ages of 18 and 30 y

• Body Mass Index between 18.5 and 30.0 kg/m2

• Able and willing to provide informed consent

Exclusion Criteria:

• A history of neuromuscular disorders or muscle/bone wasting diseases.

• Any acute or chronic illness, cardiac, pulmonary, liver, or kidney abnormalities, uncontrolled hypertension, insulin-dependent or insulin-independent diabetes, or the presence of any other metabolic disease - all of which will be determined via a medical history screening questionnaire.

• The use of any medications known to affect protein metabolism (glucocorticoids, non-steroidal anti-inflammatory medication, or prescription strength acne medication, etc.).

• A (family) history of thrombosis.

• The use of anticoagulant medications.

• Consumption of tobacco-containing products.

• Excessive alcohol consumption (>21 units/wk).

• History of bleeding diathesis, platelet or coagulation disorders, or anti-platelet/anticoagulation therapy.

• Exercise participation >2 days/wk (structured resistance and/or aerobic-type exercise)

Related Conditions & MeSH terms

• Atrophy
• Atrophy, Disuse
• Exercise
• Hypertrophy
• Muscular Disorders, Atrophic
• Proteomics

Intervention

Procedure:
• Knee bracing
Participants will have one leg immobilized, by means of a removable Don Joy Knee Brace. Participants will be expected to keep the knee brace on for 14 days, completely prevent weight bearing on the immobilized leg, and use crutches.

Other:
• Unilateral Resistance Exercise Training
Participants will perform resistance training on 4 occasions throughout an 8 day time period.

Locations

Country	Name	City	State
Canada	Exercise Metabolism Research Laboratory, McMaster Univeristy	Hamilton	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
McMaster University

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Dynamic Proteomics	The investigators will use deuterated water and skeletal muscle biopsies, paired with sensitive Gas Chromatography-Mass Spectrometry techniques to calculate the individual synthesis rate of over one hundred different skeletal muscle proteins.	Baseline, Day 5, Day 9 and Day 14 (Post)
Primary	Change in Integrated Rates of Muscle Protein Synthesis	The investigators will use deuterated water and skeletal muscle biopsies to calculate the cumulative synthesis of skeletal muscle proteins.	Baseline, Day 5, Day 9 and Day 14 (Post)
Secondary	Change in Lean Mass Using Dual X-Ray Absorptiometry	The change in lean mass (kg) will be assessed throughout the intervention using dual X-Ray absorptiometry at baseline, Day 4, and Day 8 (Post) of the intervention	Baseline, Day 5 and Day 14 (Post)
Secondary	Change in Muscle Strength using an Isokinetic Dynamometer	Muscle strength will be analyzed throughout the intervention using an isokinetic dynamometer. Isometric muscle torque (i.e., strength [N*m]) of the knee extensor will be measured.	Baseline, Day 5 and Day 14 (Post)
Secondary	Change in Muscle Cross-Sectional Area using Ultrasonography	The investigators will measure changes in vastus lateralis muscle cross sectional area (cm^2) throughout the intervention using ultrasonography.	Baseline, Day 5 and Day 14 (Post)